To include your compound in the COVID-19 Resource Center, submit it here.

Telix raises A$50M in Australian IPO

On Nov. 9, Telix Pharmaceuticals Ltd. (ASX:TLX) raised A$50 million ($38.3 million) through the

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE